Glucon Appoints New U.S.-based CEO Mr. Daniel Goldberger.BOULDER, Colo. -- Glucon (www.glucon.com), developer of a continuous, noninvasive, blood glucose monitoring blood glucose monitoring Sugar monitoring Lab medicine The periodic testing of serum glucose in Pts known to have DM. See Bedside glucose monitoring, Beta cell implants, Diabetes, Glucometer, Glycosylated hemoglobin, Non-Invasive glucose monitoring. technology for home and clinical use, announced today the appointment of Mr. Daniel Goldberger as the Company's new CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "It is estimated that the current market for glucose monitoring system devices is $5 billion a year. Clearly, this is a huge industry with a great deal of potential for those who can deliver a reliable and credible product. Glucon is developing such a device and Dan Goldberger has the necessary skill and experience to bring it successfully to market," said Allon Reiter, Vice President, Life Sciences, Giza Venture Capital. Prior to joining Glucon, Goldberger served as the President of the Medical Group of OSI Systems, Inc., responsible for revenues approaching US$200M from Patient Monitoring and Radiology products. He previously served as the President of Optiscan Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Corporation, a developer of innovative glucose monitoring products and the General Manager of Ohmeda's Oximetry oximetry /ox·im·e·try/ (ok-sim´e-tre) determination of the oxygen saturation of arterial blood using an oximeter. oximetry (oksim´itrē), n Business with revenues exceeding $50M. Goldberger earned a BSME BSME Bachelor of Science in Mechanical Engineering BSME British Schools of the Middle East (UK) BSME Business Systems Modernization Executive BSME Breeder Reactor Structural Materials (Irradiation) Experiment from the Massachusetts Institute of Technology Massachusetts Institute of Technology, at Cambridge; coeducational; chartered 1861, opened 1865 in Boston, moved 1916. It has long been recognized as an outstanding technological institute and its Sloan School of Management has notable programs in business, and an MSME MSME Micro, Small and Medium Enterprises MSME Master of Science in Mechanical Engineering MSME Mack Scogin Merrill Elam (Architects; Atlanta, GA) from Stanford University. "Dan Goldberger is a 20-year veteran of nurturing start-up LifeScience companies with high potential-products and service offerings into successful and profitable operations. Glucon has an unrivaled technology that we are confident will fill a currently unmet need in the diabetic market. It is with great pride that we welcome him to the helm and look forward to a great future for Glucon," said Dr. Dalia Megiddo, Managing Partner, InnoMed Ventures, the life science division of Jerusalem Global Ventures. "Glucon's breakthrough photoacoustic technology enables glucose levels to be read noninvasively, directly from the blood vessel. I am confident that both patients and clinicians will find Glucon's device highly beneficial and a welcomed change from the existing system of glucose monitoring," said Dan Goldberger. About Glucon Glucon, developer of a continuous, non-invasive, blood glucose (sugar) monitoring technology for home and clinical use, was founded in 2000 by two Israeli scientists, Company President Ron Nagar
|
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion